drugset / Trial / NCT04284657
Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
This is an one-year open-label study to determine treatment efficacy and feasibility of a trial that uses open-label interventions in ADPKD patients.
Timeline
- Start
- 2019-01-30
- Primary completion
- 2025-08-04
- Completion
- 2025-08-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pravastatin | Small molecule | 40 mg | Oral |
| Comparator | sodium citrate | Unknown | 30 ml | Oral |